Results 131 to 140 of about 4,080,009 (401)
Transparency and the pharmaceutical industry [PDF]
Journal of the Royal College of Physicians of Edinburgh, 2014 Carefully conducted and appropriately reported clinical trials are of fundamental importance in evidence-based medicine. This applies to both new and established treatments (see, for example, p291–2 of this issue). It is estimated that about half of all clinical trials are not reported; this is a problem of which we have been aware since 1986, if not ...
openaire +2 more sources
The Impact of Exempting the Pharmaceutical Industry from Patent Reviews [PDF]
, 2015 This paper analyzes the impact of an amendment to Senate Bill 1137, offered by Senator Thomas Tillis, which would exempt patents related to pharmaceuticals and biological products from the Inter Partes Review (IPR) process.
Dean Baker
core
Structurally Colored Physically Unclonable Functions with Ultra‐Rich and Stable Encoding Capacity
Advanced Functional Materials, Volume 35, Issue 12, March 18, 2025.This study reports a design strategy for generating bright‐field resolvable physically unclonable functions with extremely rich encoding capacity coupled with outstanding thermal and chemical stability. The optical response emerges from thickness‐dependent structural color formation in ZnO features, which are fabricated by physical vapor deposition ...
Abidin Esidir +8 more
wiley +1 more source
ACTIVE SUBSTANCES FOR DOMESTIC MANUFACTURER OF MEDICINES: PAST, PRESENT AND FUTURE
Разработка и регистрация лекарственных средств, 2019 At present, there is a tendency in Russia to switch domestic manufacturers of drugs from the system of purchases of chemical products to own production of active pharmaceutical ingredients.
K. O. Sidorov +2 more
doaj
Examining the Link Between Price Regulation, Reimportation, and Pharmaceutical R&D Investment [PDF]
This paper examines the link between price regulation and pharmaceutical research and development (R&D) investment. I identify two mechanisms through which price regulation (or re-importation) may exert an influence on R&D: an expected-profit effect and ...
Vernon, John
core +1 more source
Advanced Functional Materials, EarlyView.Hyaluronic acid‐dopamine‐based intra‐crosslinked microsphere including cisplatin (HPC MS) is fabricated by spray‐drying and calcium/iron ions are introduced for interparticle crosslinking. Designed microsphere‐aggregated hydrogel (MAH) system including cisplatin/CaO2/FeSO4 can provide apoptosis/calcicoptosis/ferroptosis‐mediated chemo/cascade ...
ChaeRim Hwang +6 more
wiley +1 more source
Frontiers in PharmacologyBackgroundThe accessibility of pediatric medicine is a global challenge. The issuance of the “Several Opinions on Ensuring the Use of Children’s Medicine” by six ministries in China in 2014 marked the formation of the policy framework. This study aims to
Qiwei Wang +8 more
doaj +1 more source
United States Food and Drug Administration and the Pharmaceutical Industry [PDF]
, 1961 Jane Garland
openalex +1 more source
Valuation in the Pharmaceutical Industry [PDF]
SSRN Electronic Journal, 2010 Valuation models are used extensively in Finance and Accounting to investigate various empirical questions. Conventional valuation models express firm value as a function of discounted dividends, discounted abnormal earnings, discounted cash flows, or price multiples.
openaire +2 more sources
Pharmaceutical Regulation and Intellectual Property: the Third Side of the Triangle [PDF]
This paper seeks to determine the interactions between industry-specific regulation law and patent law in the case of the pharmaceutical industry. It thus attempts to close the third side of the triangle formed by the vertices of antitrust, regulation ...
François Lévêque
core